Menu
  • Join
  • Login
  • Contact
 

Search abstracts


A study on effect of steroids on acute inflammatory markers in COVID-19 patients

  • At: Seville (Spain) (2022)
  • Type: Poster
  • Poster code: HMI-007
  • By: SUMALATHA, D (Vikas Institute of Pharmaceutical Sciences, India)
  • Co-author(s): Dr D Sumalatha, Pharacology (Vikas Institute of Pharmaceutical Sciences, Rajahmundry, India)
    Mr JOHN KIRUBAKARAN JOSEPH SUNDER SINGH, Scholar, Department of Pharmacy (Vikas Institute of Pharmaceutical Sciences, Rajahmundry, India)
    Dr Satya Sri Nimishakavi, Pharmacy Practice (Vikas Institute of Pharmaceutical Sciences, Rajahmundry, India)
    Dr M Sumanth, Pharmacy Practice
    Dr P Sarath Kumar, Pharmacy Practice
    Dr A Ajay Kumar, Pharmacy Practice
  • Abstract:

    Corticosteroids are a potential therapeutic agent for patients with COVID-19 pneumonia. The RECOVERY (Randomised Trials in COVID-19 Therapy) trial provided data on the mortality benefits of corticosteroids. The study aimed to determine the association between corticosteroid use on mortality and the improvement of C-reactive protein, Interleukin-6, ..

  • The access to the whole abstract and if available the presentation file is available to FIP members and to congress participants of that specific congress. Please login
Last update 4 October 2019

FIP Congresses